Anticorps Recombinant de lapin anti-PDGFR alpha/CD140a
PDGFR alpha/CD140a Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC
Conjugaison
Non conjugué
CloneNo.
241658H4
N° de cat : 98141-1-RR
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en cytométrie | MG-63 cells, |
Dilution recommandée
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
98141-1-RR cible PDGFR alpha/CD140a dans les applications de FC et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | Protéine recombinante |
Nom complet | platelet-derived growth factor receptor, alpha polypeptide |
Masse moléculaire calculée | 123 kDa |
Numéro d’acquisition GenBank | BC015186 |
Symbole du gène | PDGFR alpha |
Identification du gène (NCBI) | 5156 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Protein A purfication |
Tampon de stockage | PBS with 0.09% sodium azide |
Conditions de stockage | Store at 2 - 8°C. Stable for one year after shipment. |
Informations générales
Platelet-derived growth factor receptor alpha (PDGFR alpha, also known as CD140a) is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. PDGFRA is implicated in the regulation of embryonic development, tumorigenesis, cell proliferation, survival, and chemotaxis. Mutations in the PDGFRA gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers.
Protocole
Product Specific Protocols | |
---|---|
FC protocol for PDGFR alpha/CD140a antibody 98141-1-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |